These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27658133)

  • 1. Glycemic variability predicts inflammation in adolescents with type 1 diabetes.
    Hoffman RP; Dye AS; Huang H; Bauer JA
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1129-1133. PubMed ID: 27658133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus.
    Babar G; Clements M; Dai H; Raghuveer G
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):109-113. PubMed ID: 30710485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
    Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus.
    Chang CM; Hsieh CJ; Huang JC; Huang IC
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S171-7. PubMed ID: 22547264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes.
    Lipsky LM; Gee B; Liu A; Nansel TR
    Diabetes Res Clin Pract; 2016 Oct; 120():97-103. PubMed ID: 27525365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between oxidative stress and blood glucose fluctuations evaluated with daily glucose monitoring in children with type 1 diabetes mellitus.
    Altıncık A; Tuğlu B; Demir K; Çatlı G; Abacı A; Böber E
    J Pediatr Endocrinol Metab; 2016 Apr; 29(4):435-9. PubMed ID: 26812775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes.
    Ohara M; Fukui T; Ouchi M; Watanabe K; Suzuki T; Yamamoto S; Yamamoto T; Hayashi T; Oba K; Hirano T
    Diabetes Res Clin Pract; 2016 Dec; 122():62-70. PubMed ID: 27810687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
    Juel CTB; Dejgaard TF; Hansen CP; Storkholm JH; Vilsbøll T; Lund A; Knop FK
    J Clin Endocrinol Metab; 2021 Jan; 106(1):168-173. PubMed ID: 33053154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
    Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
    Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology.
    Sklar J; Pyle L; Snell-Bergeon JK; Garcetti R; Joshee P; Demmitt JK; Polsky S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8968-8974. PubMed ID: 34875947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control, inflammation, and cognitive function in older patients with type 2 diabetes.
    Akrivos J; Ravona-Springer R; Schmeidler J; LeRoith D; Heymann A; Preiss R; Hoffman H; Koifman K; Silverman JM; Schnaider Beeri M
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1093-100. PubMed ID: 25703191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.
    Kahkoska AR; Adair LA; Aiello AE; Burger KS; Buse JB; Crandell J; Maahs DM; Nguyen CT; Kosorok MR; Mayer-Davis EJ
    Pediatr Diabetes; 2019 Aug; 20(5):556-566. PubMed ID: 30972889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus.
    Wu JD; Xu XH; Zhu J; Ding B; Du TX; Gao G; Mao XM; Ye L; Lee KO; Ma JH
    Diabetes Technol Ther; 2011 Feb; 13(2):143-8. PubMed ID: 21284481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.